USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CUMBERLAND PHARMACEUTICALS, INC.
Address:
2525 WEST END AVE, STE 950
NASHVILLE, TN 37203-1608
Phone:
(615) 255-0068
URL:
EIN:
162176532
DUNS:
069532880
Number of Employees:
35
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $470,994.00 2

Award List:

Preclinical Development of a New Drug for Treating Anemia of Chronic Inflammation

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$246,084.00
Agency:
HHS
Principal Investigator:
Adam N. Goldfarb – 434-982-0593
Research Institution:
UNIVERSITY OF VIRGINIA
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): A strong unmet need exists to develop new treatments for anemias associated with chronic disease states, collectively referred to as anemia of chronic inflammation (ACI). ACI is highly prevalent in the U.S. and makes alarge contribution to public morbidity and… More

Targeting DNA damage response pathways for the treatment of advanced lung cancer

Award Year / Program / Phase:
2014 / STTR / Phase I
Award Amount:
$224,910.00
Agency:
HHS
Principal Investigator:
Michael L. Freeman – 615-322-3606
Research Institution:
VANDERBILT UNIVERSITY
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): There is an urgent, unmet need for novel therapeutic approaches that are efficacious against lung cancer. Ranking first among cancer deaths in the U.S., this disease has 5-year relative survival rates of lt20%. Most lung cancers are non-small cell (NSCLC, 85% of… More